Red blood cells protect albumin from cigarette smoke-induced oxidation

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Colombo, Graziano ^a   Rossi, Ranieri ^b   Gagliano, Nicoletta ^a   Portinaro, Nicola ^a   Clerici, Marco ^a   Annibal, Andrea ^a   Giustarini, Daniela ^b   Colombo, Roberto ^a   Milzani, Aldo ^a   Dalle Donne, Isabella ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CIGARETTE SMOKE; CYSTEINE; GLUTATHIONE; PLASMA PROTEIN; SERUM ALBUMIN; THIOL; THIOL DERIVATIVE;

ANTIOXIDANT ACTIVITY; ARTICLE; CARBONYLATION; CELL FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; OXIDATION; PROTEIN BLOOD LEVEL; PROTEIN MODIFICATION; BLOOD; CELL PROTECTION; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; METABOLISM; OSMOLARITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; SMOKE; SMOKING;

ACETYLCYSTEINE; CYSTEINE; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ERYTHROCYTES; GLUTATHIONE; HUMANS; OSMOLAR CONCENTRATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; SERUM ALBUMIN; SMOKE; SMOKING; SULFHYDRYL COMPOUNDS;

EID: 84855386024     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029930     Document Type: Article

References (81)

1. Patel RR, Ryu JH, Vassallo R, (2008) Cigarette smoking and diffuse lung disease. Drugs 68: 1511-1527.
2. Erhardt L, (2009) Cigarette smoking: an undertreated risk factor for cardiovascular disease. Atherosclerosis 205: 23-32.
3. Stämpfli MR, Anderson GP, (2009) How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 9: 377-384.
4. Rodgman A, Perfetti TA, (2009) The chemical components of tobacco and tobacco smoke. Boca Raton, FL CRC Press Inc.
5. van der Vaart H, Postma DS, Timens W, Ten Haccken NHT, (2004) Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 59: 713-721.
6. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF, (2007) Systemic effects of smoking. Chest 131: 1557-1566.
7. Barreiro E, Peinado VI, Galdiz JB, Ferrer E, Marin-Corral J, et al. (2010) ENIGMA in COPD Project. Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med 182: 477-488.
8. Rossi R, Giustarini D, Milzani A, Dalle-Donne I, (2009) Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings. J Cell Mol Med 13: 3131-3140.
9. Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, et al. (2002) Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 105: 1155-1157.
10. Moriarty SE, Shah JH, Lynn M, Jiang S, Openo K, et al. (2003) Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med 35: 1582-1588.
11. Giustarini D, Dalle-Donne I, Lorenzini S, Milzani A, Rossi R, (2006) Age-related influence on thiol, disulfide, and protein-mixed disulfide levels in human plasma. J Gerontol A Biol Sci Med Sci 61: 1030-1038.
12. Dalle-Donne I, Milzani A, Gagliano N, Colombo R, Giustarini D, et al. (2008) Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid Redox Signal 10: 445-473.
13. Turell L, Carballal S, Botti H, Radi R, Alvarez B, (2009) Oxidation of the albumin thiol to sulfenic acid and its implications in the intravascular compartment. Braz J Med Biol Res 42: 305-311.
14. Hortin GL, Seam N, Gerard T, Hoehn GT, (2006) Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulins. Clin Chem 52: 2258-2264.
15. Peters T Jr, (1996) The albumin molecule: Structure and chemical properties. In: Peters T, editors. All About Albumin: Biochemistry, Genetics, and Medical Applications San Diego Academic Press pp. 9-75.
16. Quinlan GJ, Martin GS, Evans TW, (2005) Albumin: biochemical properties and therapeutic potential. Hepatology 41: 1211-1219.
17. Oettl K, Stauber RE, (2007) Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 151: 580-590.
18. Oettl K, Marsche G, (2010) Redox state of human serum albumin in terms of cysteine-34 in health and disease. Methods Enzymol 474: 181-195.
19. Aldini G, Vistoli G, Regazzoni L, Gamberoni L, Maffei Facino R, et al. (2008) Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species? Chem Res Toxicol 2l: 824-835.
20. Marangon K, Devaraj S, Jialal I, (1999) Measurement of protein carbonyls in plasma of smokers and in oxidized LDL by an ELISA. Clin Chem 45: 577-578.
21. Pignatelli B, Li CQ, Boffetta P, Chen Q, Ahrens W, et al. (2001) Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res 61: 778-784.
22. Muscat JE, Kleinman W, Colosimo S, Muir A, Lazarus P, et al. (2004) Enhanced protein glutathiolation and oxidative stress in cigarette smokers. Free Radic Biol Med 36: 464-470.
23. Yeh CC, Graham Barr R, Powell CA, Mesia-Vela S, Wang Y, et al. (2008) No effect of cigarette smoking dose on oxidized plasma proteins. Environ Res 106: 219-225.
24. Nagai K, Betsuyaku T, Kondo T, Nasuhara Y, Nishimura M, (2006) Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid. Thorax 61: 496-502.
25. Suzuki M, Betsuyaku T, Ito Y, Nagai K, Nasuhara Y, et al. (2008) Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol 39: 673-682.
26. Hackett TL, Scarci M, Zheng L, Tan W, Treasure T, et al. (2010) Oxidative modification of albumin in the parenchymal lung tissue of current smokers with chronic obstructive pulmonary disease. Respir Res 11: 180-189.
27. Kim H, Liu X, Kobayashi T, Conner H, Kohyama T, et al. (2004) Reversible cigarette smoke extract-induced DNA damage in human lung fibroblasts. Am J Respir Cell Mol Biol 31: 483-490.
28. Orosz Z, Csiszar A, Labinskyy N, Smith K, Kaminski PM, et al. (2007) Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation. Am J Physiol Heart Circ Physiol 292: H130-H139.
29. Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, et al. (2008) Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 294: L478-L488.
30. Colombo G, Aldini G, Orioli M, Giustarini D, Gornati R, et al. (2010) Water-soluble α,β-unsaturated aldehydes of cigarette smoke induce carbonylation of human serum albumin. Antioxid Redox Signal 12: 349-364.
31. Schroder E, Littlechild JA, Lebedev AA, Errington N, Vagin AA, et al. (2000) Crystal structure of decameric 2-Cys peroxiredoxin from human erythrocytes at 1.7 angstrom resolution. Structure 8: 605-615.
32. Ellman GL, (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77.
33. Riddles PW, Blakeley RL, Zerner B, (1983) Reassessment of Ellman's reagent. Methods Enzymol 91: 49-60.
34. Levine RL, Williams JA, Stadtman ER, Shacter E, (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233: 346-357.
35. Eaton P, Jones ME, McGregor E, Dunn MJ, Leeds N, et al. (2003) Reversible cysteine-targeted oxidation of proteins during renal oxidative stress. J Am Soc Nephrol 14: S290-S296.
36. Dennehy MK, Richards KA, Wernke GR, Shyr Y, Liebler DC, (2006) Cytosolic and nuclear protein targets of thiol-reactive electrophiles. Chem Res Toxicol 19: 20-29.
37. Landar A, Oh JY, Giles NM, Isom A, Kirk M, et al. (2006) A sensitive method for the quantitative measurement of protein thiol modification in response to oxidative stress. Free Radic Biol Med 40: 459-468.
38. Mansoor MA, Svardal AM, Ueland PM, (1992) Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 200: 218-229.
39. De Flora S, Izzotti A, D'Agostini F, Balansky RM, (2001) Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 22: 999-1013.
40. Pendyala L, Creaven PJ, (1995) Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial. Cancer Epidemiol Biomarkers Prev 4: 245-251.
41. Turell L, Botti H, Carballal S, Ferrer-Sueta G, Souza JM, et al. (2008) Reactivity of sulfenic acid in human serum albumin. Biochemistry 47: 358-367.
42. Turell L, Botti H, Carballal S, Radi R, Alvarez B, (2009) Sulfenic acid-A key intermediate in albumin thiol oxidation. J Chromatogr B Analyt Technol Biomed Life Sci 877: 3384-3392.
43. Carballal, S, Radi R, Kirk MC, Barnes S, Freeman BA, et al. (2003) Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 42: 9906-9914.
44. Kawakami A, Kubota K, Yamada N, Tagami U, Takehana K, et al. (2006) Identification and characterization of oxidized human serum albumin: a slight structural change impairs its ligand-binding and antioxidant functions. FEBS J 273: 3346-3357.
45. Oettl K, Reibnegger G, Schmut O, (2011) The redox state of human serum albumin in eye diseases with and without complications. Acta Ophthalmol 89: e174-179.
46. Kinnula VL, (2005) Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 60: 693-700.
47. Chiou WB, Wan CS, Wu WH, Lee KT, (2011) A randomized experiment to examine unintended consequences of dietary supplement use among daily smokers: taking supplements reduces self-regulation of smoking. Addiction 106: 2221-2228.
48. Kelly GS, (2002) The interaction of cigarette smoking and antioxidants. Part I: diet and carotenoids. Altern Med Rev 7: 370-388.
49. Kelly GS, (2002) The interaction of cigarette smoking and antioxidants. Part 2: alpha-tocopherol. Altern Med Rev 7: 500-511.
50. Kelly GS, (2003) The interaction of cigarette smoking and antioxidants. Part III: ascorbic acid. Altern Med Rev 8: 43-54.
51. Møller P, Viscovich M, Lykkesfeldt J, Loft S, Jensen A, et al. (2004) Vitamin C supplementation decreases oxidative DNA damage in mononuclear blood cells of smokers. Eur J Nutr 43: 267-274.
52. Karatzi K, Papamichael C, Karatzis E, Papaioannou TG, Voidonikola PT, et al. (2007) Acute smoking induces endothelial dysfunction in healthy smokers. Is this reversible by red wine's antioxidant constituents? J Am Coll Nutr 26: 10-15.
53. Stadler N, Eggermann J, Vöö S, Kranz A, Waltenberger J, (2007) Smoking-induced monocyte dysfunction is reversed by vitamin C supplementation in vivo. Arterioscler Thromb Vasc Biol 27: 120-126.
54. Ditscheid B, Fünfstück R, Busch M, Schubert R, Gerth J, et al. (2005) Effect of L-methionine supplementation on plasma homocysteine and other free amino acids: a placebo-controlled double-blind cross-over study. Eur J Clin Nutr 59: 768-775.
55. Sharma R, Awasthi S, Zimniak P, Awasthi YC, (2000) Transport of glutathione-conjugates in human erythrocytes. Acta Biochim Pol 47: 751-762.
56. Dumaswala UJ, Zhuo L, Mahajan S, Nair PN, Shertzer HG, et al. (2001) Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBCs. Am J Physiol Cell Physiol 280: 867-873.
57. Cimen MY, (2008) Free radical metabolism in human erythrocytes. Clin Chim Acta 390: 1-11.
58. Baynes JW, (2005) Oxygen and life. In: Baynes JW, Domoniczak MH, editors. Medical Biochemistry Philadelphia Elsevier; pp. 497-506.
59. Alayash AI, Patel RP, Cashon RE, (2001) Redox reactions of hemoglobin and myoglobin: biological and toxicological implications. Antioxid Redox Signal 3: 313-327.
60. Jia L, Bonaventura C, Bonaventura J, Stamler JS, (1996) S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380: 221-226.
61. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, et al. (2003) Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9: 1498-1505.
62. Johnson RM, Goyette G Jr, Ravindranath Y, Ho YS, (2005) Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes. Free Radic Biol Med 39: 1407-1417.
63. Minetti M, Agati L, Malorni W, (2007) The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases. Cardiovasc Res 75: 21-28.
64. Wood ZA, Schroder E, Harris JR, Poole LB, (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28: 32-40.
65. Dubuisson M, Vander Stricht D, Clippe A, Etienne F, Nauser T, et al. (2004) Human peroxiredoxin 5 is a peroxynitrite reductase. FEBS Lett 571: 161-165.
66. Romero N, Denicola A, Radi R, (2006) Red blood cells in the metabolism of nitric oxide-derived peroxynitrite. IUBMB Life 58: 572-580.
67. Yang KS, Kang SW, Woo HA, Hwang SC, Chae HZ, et al. (2002) Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J Biol Chem 277: 38029-38036.
68. Biteau B, Labarre J, Toledano MB, (2003) ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425: 980-984.
69. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM, (2004) Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304: 596-600.
70. Kang SW, Rhee SG, Chang T-S, Jeong W, Choi MH, (2005) 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol Med 11: 571-578.
71. Low FM, Hampton MB, Peskin AV, Winterbourn CC, (2007) Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 109: 2611-2617.
72. Peskin AV, Low FM, Paton LN, Maghzal GJ, Hampton MB, et al. (2007) The high reactivity of peroxiredoxin 2 with H(2)O(2) is not reflected in its reaction with other oxidants and thiol reagents. J Biol Chem 282: 11885-11892.
73. Low FM, Hampton MB, Winterbourn CC, (2008) Peroxiredoxin 2 and peroxide metabolism in the erythrocyte. Antioxid Redox Signal 10: 1621-1630.
74. Manta B, Hugo M, Ortiz C, Ferrer-Sueta G, Trujillo M, et al. (2009) The peroxidase and peroxynitrite reductase activity of human erythrocyte peroxiredoxin 2. Arch Biochem Biophys 484: 146-154.
75. Lim Y-S, Cha M-K, Yun C-H, Kim H-K, Kim K, et al. (1994) Purification and characterization of thiol-specific antioxidant protein from human red blood cell: a new type of antioxidant protein. Biochem Biophys Res Commun 199: 199-206.
76. Cha M-K, Yun C-H, Kim I-H, (2000) Interaction of human thiol-specific antioxidant protein 1 with erythrocyte plasma membrane. Biochemistry 39: 6944-6950.
77. Boas FE, Forman L, Beutler E, (1998) Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci USA 95: 3077-3081.
78. Polidori MC, Mecocci P, Wilhelm Stahl W, Sies H, (2003) Cigarette smoking cessation increases plasma levels of several antioxidant micronutrients and improves resistance towards oxidative challenge. Br J Nutr 90: 147-150.
79. Louhelainen N, Rytilä P, Haahtela T, Kinnula VL, Djukanović R, (2009) Persistence of oxidant and protease burden in the airways after smoking cessation. BMC Pulm Med 9: 25-33.
80. Minetti M, Malorni W, (2006) Redox control of red blood cell biology: the red blood cell as a target and source of prooxidant species. Antioxid Redox Signal 8: 1165-1169.
81. Halliwell B, Gutteridge JMC, (2007) Free Radicals in Biology and Medicine. 4th edition. New York Oxford University Press, Inc.